Luminescent Assay for the Screening of SARS‐CoV‐2 M(Pro) Inhibitors

Since the outbreak of SARS‐CoV‐2 in December 2019 millions of infections have been reported globally. The viral chymotrypsin‐like main protease (M(Pro)) exhibits a crucial role in viral replication and represents a relevant target for antiviral drug development. In order to screen potential M(Pro) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sondag, Daan, Merx, Jona, Rossing, Emiel, Boltje, Thomas J., Löwik, Dennis W. P. M., Nelissen, Frank H. T., van Geffen, Mark, van 't Veer, Cornelis, van Heerde, Waander L., Rutjes, Floris P. J. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401586/
https://www.ncbi.nlm.nih.gov/pubmed/35649961
http://dx.doi.org/10.1002/cbic.202200190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401586/
https://www.ncbi.nlm.nih.gov/pubmed/35649961
http://dx.doi.org/10.1002/cbic.202200190

Ejemplares similares